Ketamine Archives - Psychiatry Advisor

By

Sheila Jacobs

September 6, 2017

Ketamine dosing continues to raise safety concerns.

By

July 1, 2016

Neuroimaging studies have shown several neurophysiological substrates for depression: An overview by Theodore Henderson, MD, PhD.

By

Tori Rodriguez, MA, LPC

May 23, 2016

Byproduct of ketamine metabolism underlies the antidepressant-like activity of the agent in mice.

By

Jonathan Block

January 8, 2016

China’s U.N. delegation has argued that ketamine is a health risk when it is used in a recreational fashion.

By

Jonathan Block

May 17, 2015

Ketamine and other drugs targeting the brain’s NMDA receptors may benefit treatment-resistant depression.

Ketamine